Skip to content

CRON

Cronos Group, Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA

$3.52
+4.02%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+28.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 20, 2026Martens Christopher · officer: General ManagerA-Award46,875$0.00
Aug 7, 2026Garnick Murray R · directorA-Award48,860$0.00
Aug 7, 2026RUDYK JAMES DANIEL · directorA-Award48,860$0.00
Aug 7, 2026ADLER JASON MARC · directorA-Award48,860$0.00
May 14, 2026Kenost Jared Matthew · officer: See RemarksM-Exempt9,412$0.00
May 14, 2026Buggy Shannon · officer: See RemarksF-InKind9,179$2.75
May 14, 2026Kenost Jared Matthew · officer: See RemarksF-InKind3,701$2.75
May 14, 2026Doucet Terrence Gregory Joseph · officer: See RemarksM-Exempt10,597$0.00
May 14, 2026Doucet Terrence Gregory Joseph · officer: See RemarksF-InKind5,199$3.75
May 14, 2026Kenost Jared Matthew · officer: See RemarksA-Award30,000$0.00
May 14, 2026Buggy Shannon · officer: See RemarksM-Exempt20,622$0.00
May 14, 2026Wagner Adam · officer: See remarksM-Exempt10,367$0.00
May 12, 2026Wagner Adam · officer: See remarksM-Exempt10,063$0.00
May 12, 2026Kenost Jared Matthew · officer: See RemarksF-InKind2,896$2.54
May 12, 2026Wagner Adam · officer: See remarksM-Exempt10,407$0.00
May 12, 2026Kenost Jared Matthew · officer: See RemarksF-InKind1,878$2.54
May 12, 2026Weigensberg Arye · officer: See RemarksM-Exempt3,118$0.00
May 12, 2026Kenost Jared Matthew · officer: See RemarksM-Exempt7,535$0.00
May 12, 2026Kenost Jared Matthew · officer: See RemarksM-Exempt5,114$0.00
Mar 20, 2026Shlimak Anna · officer: See RemarksF-InKind9,767$2.54
Mar 20, 2026Shlimak Anna · officer: See RemarksM-Exempt28,429$0.00
Mar 17, 2026Shlimak Anna · officer: See RemarksM-Exempt45,226$0.00
Mar 17, 2026Shlimak Anna · officer: See RemarksF-InKind16,354$2.50
Mar 17, 2026GORENSTEIN MICHAEL RYAN · director, officer: See remarks belowF-InKind127,706$2.50
Mar 17, 2026JACOBSON JEFFREY DAVID · officer: Chief Growth OfficerM-Exempt59,191$0.00
Mar 17, 2026GORENSTEIN MICHAEL RYAN · director, officer: See remarks belowM-Exempt324,540$0.00
Mar 17, 2026Weigensberg Arye · officer: See RemarksM-Exempt24,236$0.00
Mar 17, 2026Buggy Shannon · officer: See RemarksM-Exempt20,938$0.00
Mar 17, 2026Doucet Terrence Gregory Joseph · officer: See RemarksF-InKind12,276$3.44
Mar 17, 2026JACOBSON JEFFREY DAVID · officer: Chief Growth OfficerF-InKind22,552$2.50
Institutional positioning

13F filings over the trailing two quarters

New 51Increased 76Reduced 97Sold out 42
FilerActionSharesFiled
D. E. Shaw & Co., Inc.Increased8,840,503Aug 14, 2026
CHESCAPMANAGER LLCUnchanged7,942,737May 14, 2026
Chescapmanager LLCUnchanged7,942,737Aug 14, 2026
D. E. SHAW & CO., INC.Increased7,618,227May 15, 2026
Pillsbury Lake Capital LLCIncreased4,223,004May 14, 2026
TOROSO INVESTMENTS, LLCReduced4,026,892May 15, 2026
Tidal Investments LLCReduced3,767,849Aug 13, 2026
DIMENSIONAL FUND ADVISORS LPIncreased3,048,254Aug 11, 2026
DIMENSIONAL FUND ADVISORS LPIncreased2,679,051May 7, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced2,169,367May 15, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased2,009,549May 14, 2026
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPNew Position1,992,855Aug 13, 2026
MACKENZIE FINANCIAL CORPIncreased1,873,116Nov 2, 2026
RENAISSANCE TECHNOLOGIES LLCReduced1,742,149Aug 13, 2026
MACKENZIE FINANCIAL CORPNew Position1,597,039Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 20, 2026